September healthtech funding roundup: Who raised what

A list of healthtech funding news we came across this month.
September healthtech funding roundup

September was another active month for healthtech, with startups across AI, oncology, kidney care, and digital health securing major rounds. 

Here’s a look at the biggest funding news we came across this month

Strive Health – Kidney Care

  • Funds Raised: $550 Mn ($300 Mn equity + $250 Mn debt)
  • Round: Series D equity + debt financing
  • Investors: NEA (equity), Hercules Capital (debt)
  • About: Denver-based Strive Health is a value-based care provider for kidney disease patients.

Inspiren – Healthcare AI

  • Funds Raised: $100 Mn
  • Round: Series B
  • Investors: Insight Partners
  • About: New York-based Inspiren develops an AI-powered platform and connected device system for senior living communities.

Ollin Biosciences – Ophthalmology Therapies

  • Funds Raised: $100 Mn
  • Round: Initial funding
  • Investors: Arch Venture Partners, Mubadala, Monograph Capital
  • About: Austin-based Ollin Biosciences is a clinical-stage biotech developing therapies for vision-threatening diseases.

Galvanize Therapeutics – Medical Devices

  • Funds Raised: $100 Mn
  • Round: Series C
  • Investors: Sofinnova Partners
  • About: California-based Galvanize develops pulsed electric field therapies for oncology and chronic lung diseases.

Thyme Care – Oncology Care

  • Funds Raised: $97 Mn
  • Round: Series D
  • Investors: CVS Health, Humana, Morgan Health and Memorial Hermann
  • About: Nashville-based Thyme Care provides value-based care services for oncology patients.

The Sunrise Group – Sleep Health

  • Funds Raised: $29 Mn
  • Round: Growth round
  • Investors: Eurazeo, Amazon’s Alexa fund and others
  • About: US based Sunrise Group is developing a digital sleep clinic, Dreem Health, to provide end-to-end virtual sleep care.

Optain Health – AI Retinal Imaging

  • Funds Raised: $26 Mn
  • Round: Series A
  • Investors: Insight Partners, Memorial Hermann, Northwell Health, Novant Health, Ohio State Wexner Medical Center, and UPMC.
  • About: Optain Health is scaling its AI-powered retinal imaging and teleophthalmology platform

AmplifyMD – Virtual Specialty Care

  • Funds Raised: $20 Mn
  • Round: Series B
  • Investors: Forerunner Ventures, Memorial Hermann Health System, F-Prime Capital, Greylock Partners and Tau Ventures. 
  • About: AmplifyMD provides an AI-driven virtual specialty care platform and physician network for hospitals.

Hello Patient – Conversational AI for Patient Engagement

  • Funds Raised: $22.5 Mn
  • Round: Series A
  • Investors: Scale Venture Partners, 8VC, Bling Capital, Max Ventures, Remus Capital, FirstLook Partners
  • About: Hello Patient is reinventing the patient intake and engagement experience, positioning itself as healthcare’s digital front door.

FlexifyMe – AI Physiotherapy

  • Funds Raised: ₹20 Cr (~$2.4 Mn)
  • Round: Pre-Series A
  • Investors: IvyCap Ventures, Signal Ventures and other existing investors.
  • About: India-based FlexifyMe offers AI-powered physiotherapy-based diagnosis and pain management solutions.

Seven Starling – Maternal Mental Health

  • Funds Raised: $8 Mn
  • Round: Seed/Growth round
  • Investors: Rethink Impact, Pear VC, Zeal Capital Partners, Magnify Ventures, Ulu Ventures, Expa, Fiore Ventures, the March of Dimes, Rogue Women’s Fund, and Graham & Walker.
  • About: Virtual women’s behavioral health company focused on expanding access to maternal mental health support.

Reveal HealthTech – Healthcare AI Enablement

  • Funds Raised: $7.2 Mn
  • Round: Seed/Growth round
  • Investors: Leo Capital, Sanos Capital, W Health Ventures, 2070 Health
  • About: Reveal HealthTech is building trusted AI solutions for healthcare delivery.

Revalia Bio – Organ Testing Platform

  • Funds Raised: $14.5 Mn
  • Round: Seed
  • Investors: America’s Frontier Fund, Sierra Ventures, Roger Ferguson
  • About: Revalia Bio develops organ-on-chip platforms to help companies test new therapies on human organs outside the body to provide predictive preclinical insight.

OpenHealth Technologies – Lab Data AI

  • Funds Raised: $3 Mn
  • Round: Seed
  • Investors: GoHub Ventures, xDeck Ventures, Edenbase, Exceptional Ventures, YZR Capital
  • About: OpenHealth unlocks lab data using AI to accelerate diagnostics and healthcare research.

Aiomics – AI Documentation Tools

  • Funds Raised: €2 Mn (~$2.1 Mn)
  • Round: Seed
  • Investors: Vorwerk Ventures, Calm/Storm ventures, Norrsken Evolve, Rule30 and other angel investors.
  • About: German startup Aiomics helps reduce medical documentation time with its AI-powered platform.

Takeaway

September saw mega-rounds like Strive Health ($550 Mn total) alongside early-stage bets on AI, digital health, and precision therapies. The mix shows how investors continue to back both platform-scale healthtech companies and emerging niche innovations.

Total
0
Shares
Previous Post
World medical innovation forum 2025 WMIF 2025

A complete recap of World Medical Innovation Forum 2025: Insights & takeaways

Next Post
Clara by Rescripted, LLM for women's health

Clara by Rescripted: The first LLM built exclusively for women’s health

Related Posts